Compare · SYM vs TMO
SYM vs TMO
Side-by-side comparison of Symbotic Inc. (SYM) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SYM and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $232.26B, about 9.5x SYM ($24.44B).
- SYM has been more active in the news (13 items in the past 4 weeks vs 10 for TMO).
- Both have 25 recent analyst ratings on file.
- Company
- Symbotic Inc.
- Thermo Fisher Scientific Inc
- Price
- -
- -
- Market cap
- $24.44B
- $232.26B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 13
- 10
- Recent ratings
- 25
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest SYM
- Chief Technology Officer Kuffner James sold $160,422 worth of shares (3,952 units at $40.59) and converted options into 9,748 shares, increasing direct ownership by 3% to 219,858 units (SEC Form 4) to cover withholding tax
- Symbotic Joins Stanford Robotics Center Industrial Affiliates Program
- Industrial Robot Installations Hit Record Highs Amid Labor Shortage Crisis
- SEC Form 3 filed by new insider Pagliuca Stephen G
- SEC Form 4 filed by Director Pagliuca Stephen G
- Amendment: SEC Form SCHEDULE 13D/A filed by Symbotic Inc.
- Director Krasnow Todd acquired 2,000 shares as part of a pre-agreed trading plan, sold $90,538 worth of shares (2,000 units at $45.27) as part of a pre-agreed trading plan and disposed of 2,000 units of Class V-1 Common Stock as part of a pre-agreed trading plan (SEC Form 4)
- Director Kane Charles sold $86,420 worth of shares (2,000 units at $43.21) as part of a pre-agreed trading plan, disposed of 2,000 units of Class V-1 Common Stock as part of a pre-agreed trading plan and acquired 2,000 shares as part of a pre-agreed trading plan, decreasing direct ownership by 85% to 89,852 units (SEC Form 4)
- Chief Financial Officer Martins Izilda P converted options into 59,134 shares and sold $1,120,490 worth of shares (27,463 units at $40.80), increasing direct ownership by 905% to 35,171 units (SEC Form 4) (for tax liability)
- SEC Form 10-Q filed by Symbotic Inc.
Latest TMO
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 31 shares, decreasing direct ownership by 0.53% to 5,830 units (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 20,000 shares at a strike of $309.63 and sold $12,561,823 worth of shares (20,000 units at $628.09) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. sold $7,014,093 worth of shares (11,440 units at $613.12) and exercised 11,440 shares at a strike of $418.32, decreasing direct ownership by 0.00% to 14,784 units (SEC Form 4)
- Executive Vice President Shafer Michael D exercised 25,500 shares at a strike of $370.58 and sold $15,300,000 worth of shares (25,500 units at $600.00) as part of a pre-agreed trading plan (SEC Form 4)
- Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
- VP & Chief Accounting Officer Holmes Joseph R. exercised 420 shares at a strike of $309.63 and sold $245,620 worth of shares (420 units at $584.81) (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 275 shares at a strike of $309.63 and sold $2,862,002 worth of shares (4,883 units at $586.12) as part of a pre-agreed trading plan (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. exercised 5,850 shares at a strike of $309.63 and sold $3,393,000 worth of shares (5,850 units at $580.00), decreasing direct ownership by 0.00% to 14,784 units (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 10,000 shares at a strike of $309.63 and sold $8,616,967 worth of shares (15,000 units at $574.46) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 10,000 shares at a strike of $309.63 and sold $8,628,434 worth of shares (15,000 units at $575.23) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)